COVID-19: China approves human trials of two vaccines

Tashkent, Uzbekistan (UzDaily.com) -- China has approved human testing of two vaccines to combat the coronavirus or COVID-19 pandemic, Xinhua News Agency reported.

The two vaccines have been developed by the Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing.

These are first vaccines in the world cleared for clinical trials, claimed the Global Times, a daily newspaper while quoting the Supervision and Administration Commission of the State Council.

Sinopharm has produced over 50,000 doses for the initial clinical trials. After production is normalized, the output could reach 3 million doses per batch with annual output at 100 million doses, the state-run media outlet added.